What Works Skin — Independent · Evidence-First · Ad-FreeIssue 014 · 20 April 2026 · Next: 04 Maywhatworksskin.com
What WorksSkin
Search/
INGREDIENT · 27 / 28FILED · 20 APR 2026

Ingredient · Cell-derived vesicles · Cosmetic exosomes

P. 27 · BRIEF

Exosomes (cosmetic).

Real biology, premature product. The most expensive maybe in skincare.

Exosome biology is one of the most exciting areas of regenerative medicine. The translation to a $400 cosmetic serum is, frankly, not. The honest framing: real molecules, no proper topical evidence, real regulatory grey area, and pricing that depends almost entirely on the absence of scrutiny.

— § 01

What cosmetic exosomes actually are.

Exosomes are small membrane-bound vesicles (30–150 nm) that cells release as part of intercellular communication. They carry proteins, lipids, and nucleic acids and are a genuine area of regenerative-medicine research — for things like wound healing, post-operative recovery, and inflammation modulation, mostly via injection or directed delivery in clinical trials.

Cosmetic exosomes — typically derived from plant cells, salmon, or human-cell-line cultures — are sold as topical serums on the pitch that those vesicles will reach the dermis and deliver regenerative cargo. They almost certainly do not. The stratum corneum exists. The vesicles, even at the smaller end of the size range, are an order of magnitude too large to passively cross intact skin.

⁂

— § 02

Mechanism, plainly.

On the surface

Modest humectant and supportive role from accompanying ingredients (HA, peptides, antioxidants in the vehicle).

On dermal regeneration

Claimed but not demonstrated for topical application on intact skin. Marketing outpaces evidence by a wide margin.

Post-procedure (microneedled / laser)

Some weak signal when applied to compromised skin barrier — but evidence is small, mostly industry-funded, and not yet replicated.

⁂

— § 03

The evidence.

Topical anti-aging (intact skin)
Industry-led / small

Claims dramatic; data does not match. Mostly observational and unblinded.

22%
Post-microneedling adjunct
Smaller RCTs

Some signal when delivered through compromised barrier; replication needed.

44%
Wound / post-procedure (clinical)
Early clinical trials

The honest area — therapeutic context, controlled delivery, dermatologist-led.

60%
Topical 'regeneration' (consumer)
Marketing only

The headline claim. Not supported by meaningful topical evidence.

10%
⁂

— § 04

Concentration & vehicle.

Particle counts
Variable

Brand-to-brand 1000x differences with no standard. Specs are marketing.

Cold-chain required
Most products

If your bottle ships at room temperature, you are buying degradation products.

+ Vitamin C / peptides
Vehicle effect

Most measured benefit comes from the supporting ingredients, not the exosomes.

⁂

— § 06

Pairings & conflicts.

In-clinic microneedling
Promising
The honest use case — applied through a compromised barrier under clinical control. Even here, evidence is early.
Standalone topical use
Avoid (overpriced)
$200–500 per bottle for unproven topical effect. The supporting actives could be bought à la carte.
Retinoids
Compatible
Layer freely; no incompatibility, but no demonstrated synergy either.
Pregnancy
Avoid
Insufficient data on bioactive cargo; conservative avoidance.
Room-temperature storage
Avoid
Most cosmetic exosomes degrade rapidly without cold chain. Refrigerate or skip.
⁂

— § 07

On our shelf.

Various clinical brandsTier D
ASCE+ / ExoCobio / Plated

Market leaders by price; evidence base is thin. Cold-chain compliance variable.

48⁄100Not yet reviewed
Salmon-PDRN serumsTier D
Plump'n Glow / Rejuran-adjacent

Different molecule (polynucleotides), often marketed alongside exosome claims. Topical case still weak.

50⁄100Not yet reviewed
MedicubeTier D
Exosome Shot 2000

Plant-derived exosome essence — cheaper than ASCE+, even less translational evidence. Most of the perceived benefit comes from the supporting actives in the base.

44⁄100Not yet reviewed
BenevTier C
Exosome Regenerative Complex+

The credible use case: applied by clinicians as a microneedling adjunct under cold-chain conditions. Operator-dependent and evidence still emerging, but the most defensible exosome product on the market today.

62⁄100Not yet reviewed
⁂

— § 08

Frequently asked.

Why is this Tier D?

Because the gap between the claimed benefits and the demonstrated topical evidence is the largest in the entire library. Real biology, premature product. We expect to revisit this in 2028 when the trial data catches up.

Is exosome science fake?

No, the basic biology is robust and exosome therapeutics are an active clinical research area. The fakeness lives in the cosmetic translation and pricing, not in the underlying science.

Should I get the in-clinic exosome facial?

Maybe, with a dermatologist who can speak to source, sterility, and protocol. The clinical context is the only place exosomes have a credible cosmetic application today.

Is it FDA-approved?

No exosome cosmetic product is FDA-approved as a drug. Most are sold as cosmetics under the 'cosmetic' regulatory floor, which requires no efficacy proof. Safety oversight is similarly minimal.

⁂
⁂

Continue Reading

Read next.

Similar Ingredient

Adapalene

Graded Tier A. The only OTC retinoid the FDA has approved specifically for acne. Selective for ...

Read brief →